Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine
Autor: | Liu-yong Zhou, Jian-liang You, Zhen-zhu Shan |
---|---|
Rok vydání: | 2009 |
Předmět: |
Adult
Male medicine.medical_specialty Organoplatinum Compounds Colorectal cancer medicine.medical_treatment Traditional Chinese medicine Adenocarcinoma Pharmacology Gastroenterology Quality of life Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Pharmacology (medical) Medicine Chinese Traditional Survival rate Survival analysis Aged Aged 80 and over Chemotherapy business.industry Combination chemotherapy General Medicine Middle Aged medicine.disease Antineoplastic Agents Phytogenic Combined Modality Therapy Survival Analysis Oxaliplatin Treatment Outcome Complementary and alternative medicine Colonic Neoplasms Quality of Life Female Fluorouracil business Drugs Chinese Herbal medicine.drug |
Zdroj: | Chinese Journal of Integrative Medicine. 15:107-111 |
ISSN: | 1993-0402 1672-0415 |
Popis: | To observe the clinical effect of combined chemotherapy and Chinese herbal medicine in treating colonic cancer. One hundred and sixty-three patients were assigned, according to their will, to two groups, 105 in the traditional Chinese medicine treated group (Group A) and 58 in the combined treatment group (Group B). The Chinese herbal drug Zhao’s Weitiao No. 3 (赵氏微调 3号方, ZW3) was given to both groups, twice a day, 40 mL each time, 30 days as one cycle, and over 6 cycles applied in total. For patients in Group B, the chemotherapy of OLF protocol (L-OHP+LV+5-FU) was given for 4–6 cycles. The effects of treatment on the main symptoms, tumor mass, patients’ quality of life (QOL) and body weight, changes of carcino-embryonic antigen (CEA), as well as the integral effect and survival rate were observed and compared. The total effective rate in Group A and Group B was 89.52% and 86.21% respectively, on the main clinical symptoms; 86.67% and 93.10% on tumor mass, 82.86% and 77.59% on QOL, 85.71% and 75.86% on body weight and 76.19% and 79.31% on CEA. The integral efficacy of total beneficial rate was 73.33% and 68.97%; and the 3-year survival rate 49.52% and 46.65% in Group A and Group B. These data showed that the effect in Group A was better than in Group B in terms of clinical symptom improvement, QOL, body weight and integral beneficence increase and survival rate, though it was inferior in reducing the tumor mass and CEA level. Chinese drug ZW3 for the treatment of colonic cancer could improve the main clinical symptoms, improve the QOL, increase body weight and prolong the survival time of patients, showing a favorable integral effect. |
Databáze: | OpenAIRE |
Externí odkaz: |